These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 25956682)

  • 1. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.
    Pu J; Frescas D; Zhang B; Feng J
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1065-70. PubMed ID: 25956682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
    Cuculis L; Schroeder CM
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TALEN or Cas9 - rapid, efficient and specific choices for genome modifications.
    Wei C; Liu J; Yu Z; Zhang B; Gao G; Jiao R
    J Genet Genomics; 2013 Jun; 40(6):281-9. PubMed ID: 23790627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
    Chang CY; Ting HC; Su HL; Jeng JR
    Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas-mediated targeted genome editing in human cells.
    Yang L; Mali P; Kim-Kiselak C; Church G
    Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.
    Brookhouser N; Raman S; Potts C; Brafman DA
    Cells; 2017 Feb; 6(1):. PubMed ID: 28178187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in genome editing technology and its promising application in evolutionary and ecological studies.
    Chen L; Tang L; Xiang H; Jin L; Li Q; Dong Y; Wang W; Zhang G
    Gigascience; 2014; 3():24. PubMed ID: 25414792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing for human gene therapy.
    Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
    Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
    Zhao G; Pu J; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome Editing of Rat.
    Kaneko T
    Methods Mol Biol; 2017; 1630():101-108. PubMed ID: 28643253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
    Cottle RN; Lee CM; Archer D; Bao G
    Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
    Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
    Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.